Charles Theuer - 16 Aug 2021 Form 4 Insider Report for Tracon Pharmaceuticals, Inc.

Role
President and CEO, Director
Signature
/s/ Scott B. Brown, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
16 Aug 2021
Net transactions value
+$10,680
Form type
4
Filing time
18 Aug 2021, 06:05:08 UTC
Previous filing
27 May 2021
Next filing
09 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCON Common Stock Purchase $10,680 +3,000 +1.5% $3.56 207,732 16 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 3500 shares acquired by the Reporting Person under the Issuer's 2015 Employee Stock Purchase Plan on April 20, 2021.